 BEDMER, N.J.--BUSINESS WIRE--TYME Technologies, Inc. Nasdaq: TYME the Company or TYME, an emerging biotechnology company developing cancer metabolism-based therapies CMBTsTM, today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business Officer, will present at the Jefferies London Healthcare Conference as follows: Date: Wednesday, November 17, 2021 Time: 1:40 PM Greenwich Mean Time 8:40 AM Eastern Standard Time Webcast: 